Reported Aug 8, 2018 · Terminated

Moxifloxacin Ophthalmic Solution USP, 0.5%, 5 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals Inc.…

Lupin Pharmaceuticals Inc.

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Lupin Pharmaceuticals Inc. · 111 S Calvert St Fl 21ST · Baltimore, MD · 21202-6174

Is this the product you have?

  • Moxifloxacin Ophthalmic Solution USP, 0.5%, 5 mL bottle, Rx only
  • Manufactured forLupin Pharmaceuticals Inc. Baltimore, Maryland 21202 United States
  • Manufactured by
    • Lupin Limited Pithampur (M.P.) 454 775
    • INDIA
    • NDC 68180-422-01
Lot codes and dates
    • Lot #: H800393
    • Exp. 01/2020
Amount recalled
13,896 bottles

Why it was recalled

Failed Impurities/Degradation Specifications: An out-of-specification result in the related substance test during three month long-term stability study.

This product is unlikely to cause harm, but it breaks a safety or labelling rule.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Lupin Pharmaceuticals Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Dec 6, 2019 · Data as of Sep 19, 7:53 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.